Understanding Osteoporosis Medications (cont.)
- Zoledronic acid (Zometa): This drug is an injectable bisphosphonate that can be administered annually for individuals unable to take or tolerate oral bisphosphonates. It is currently approved by the US Food and Drug Administration (FDA) for bone metastases in individuals with cancer.
- Etidronate (Didronel): This is another bisphosphonate approved by the FDA for treatment in Paget's disease.
- Lasofoxifene: This is a SERM that decreases bone loss. It has favorable effects on blood cholesterol level and may prevent the growth of certain breast cancer cells.
- Basedoxifene: This is another SERM currently undergoing clinical trials.
- Strontium (Protos): This is an oral drug in development in Europe, Australia, and Japan. It decreases breakdown of bone and increases bone formation.
Francisco Talavera, PharmD, PhD
Must Read Articles Related to Understanding Osteoporosis Medications
Hormone Replacement and Osteoporosis
Hormones are produced by glands in our bodies. They are chemicals that have specific effects on different parts of our bodies. For example, the ovaries produce ...learn more >>
Osteoporosis is a disease characterized by low bone mass and loss of bone tissue that may lead to weak and fragile bones. If you have osteoporosis, you have an ...learn more >>
Osteoporosis (or porous bone) is a disease in which bone loss occurs, so bones become weak and are more likely to break. This FAQ includes information about tre...learn more >>